Healthcare provider profile · identity verified

Eric J Glantz, D.O.

Family Practice · LAKEWOOD, NJ · NPI 1821385568

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	90
Pantoprazole Sodium	Pantoprazole Sodium	322	61
Levothyroxine Sodium	Levothyroxine Sodium	314	52
Eliquis	Apixaban	243	31
Losartan Potassium	Losartan Potassium	240	47
Gabapentin	Gabapentin	232	47
Furosemide	Furosemide	231	66
Metoprolol Succinate	Metoprolol Succinate	222	49
Amlodipine Besylate	Amlodipine Besylate	174	42
Metformin Hcl	Metformin Hcl	164	33
Famotidine	Famotidine	153	28
Levetiracetam	Levetiracetam	126	15
Potassium Chloride	Potassium Chloride	120	32
Trazodone Hcl	Trazodone Hcl	114	28
Lisinopril	Lisinopril	105	20
Sertraline Hcl	Sertraline Hcl	104	19
Clopidogrel	Clopidogrel Bisulfate	99	18
Escitalopram Oxalate	Escitalopram Oxalate	97	21
Rosuvastatin Calcium	Rosuvastatin Calcium	97	23
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	92	18
Alogliptin	Alogliptin Benzoate	90	14
Bupropion Xl	Bupropion Hcl	89	17
Tamsulosin Hcl	Tamsulosin Hcl	88	23
Carvedilol	Carvedilol	83	18
Quetiapine Fumarate	Quetiapine Fumarate	82	23
Metformin Hcl Er	Metformin Hcl	74	15
Ezetimibe	Ezetimibe	71	14
Donepezil Hcl	Donepezil Hcl	69	12
Mirtazapine	Mirtazapine	65	18
Allopurinol	Allopurinol	63	13
Prednisone	Prednisone	61	33
Valsartan	Valsartan	61	12
Pravastatin Sodium	Pravastatin Sodium	58	12
Glipizide Er	Glipizide	55	suppressed
Solu-Cortef	Hydrocortisone Sodium Succ/Pf	54	suppressed
Latanoprost	Latanoprost	53	14
Spironolactone	Spironolactone	49	11
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	46	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	46	12
Duloxetine Hcl	Duloxetine Hcl	45	13
Hydroxyzine Hcl	Hydroxyzine Hcl	45	14
Xarelto	Rivaroxaban	45	12
Fluticasone-Vilanterol	Fluticasone/Vilanterol	44	12
Lactulose	Lactulose	43	18
Trulicity	Dulaglutide	43	11
Nifedipine Er	Nifedipine	42	suppressed
Torsemide	Torsemide	42	suppressed
Alprazolam	Alprazolam	41	13
Dapagliflozin	Dapagliflozin Propanediol	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Divalproex Sodium Er	Divalproex Sodium	40	suppressed
Mirabegron Er	Mirabegron	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	16
Insulin Lispro Kwikpen U-100	Insulin Lispro	38	11
Prazosin Hcl	Prazosin Hcl	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Sucralfate	Sucralfate	37	suppressed
Digoxin	Digoxin	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	17
Glipizide	Glipizide	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Clonidine	Clonidine	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	17
Risperidone	Risperidone	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	31	14
Colchicine	Colchicine	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Methenamine Hippurate	Methenamine Hippurate	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Cephalexin	Cephalexin	29	22
Mupirocin	Mupirocin	29	16
Oxycodone Hcl	Oxycodone Hcl	29	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	11
Ssd	Silver Sulfadiazine	27	16
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	20
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Omeprazole	Omeprazole	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	11
Paliperidone Er	Paliperidone	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	16
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	16
Finasteride	Finasteride	21	suppressed
Fluconazole	Fluconazole	21	16
Cefuroxime	Cefuroxime Axetil	20	16
Ingrezza	Valbenazine Tosylate	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Ozempic	Semaglutide	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Rezvoglar Kwikpen	Insulin Glargine-Aglr	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Xifaxan	Rifaximin	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Nystatin	Nystatin	15	13
Amantadine	Amantadine Hcl	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Cefepime Hcl	Cefepime Hcl	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Nyamyc	Nystatin	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Alogliptin-Metformin	Alogliptin Benz/Metformin Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Nifedipine	Nifedipine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystop	Nystatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cardura Xl	Doxazosin Mesylate	11	suppressed
Diazepam	Diazepam	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Horizant	Gabapentin Enacarbil	11	suppressed
Levetiracetam Er	Levetiracetam	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Simvastatin	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error